Bain Capital Specialty Finance, Inc. current report, 04 October 2017

Business Context and Reporting Period

This Form 8-K was filed by Bain Capital Specialty Finance, Inc. on October 4, 2017. The report details the entry into a material definitive agreement and the creation of a direct financial obligation on the same date.

Key Financial Metrics and Agreements

The Company entered into a Revolving Credit Agreement with Goldman Sachs Bank USA as the Sole Lead Arranger and U.S. Bank National Association as the Collateral Administrator.

  • Facility Amount: $500,000,000, with an option to increase to $750,000,000.
  • Maturity Date: October 5, 2022, or earlier upon acceleration.
  • Permitted Uses: Acquisition of qualifying loans and other permitted uses.
  • Covenants: Includes customary affirmative and negative covenants, limitations on additional indebtedness and liens, and standard events of default.

The filing does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels as this is a current report regarding a specific transaction rather than a periodic financial statement.

Material Changes

The primary material change is the establishment of a new $500 million revolving credit facility, which alters the Company's liquidity position and debt capacity. No prior comparable period data is provided in this filing to assess changes in operating metrics.

Guidance, Outlook, and Risks

Management commentary is limited to the summary of the credit agreement terms. The agreement includes standard risks associated with revolving credit facilities, including covenants limiting additional indebtedness and liens. The full text of the agreement, containing detailed risk factors and covenants, is scheduled to be filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ending September 30, 2017.

Key Facts for Investor Verification

  • Verify the full text of the Revolving Credit Agreement in the upcoming Form 10-Q for the quarter ended September 30, 2017.
  • Confirm the specific interest rate terms and fees associated with the $500 million facility, which are not detailed in this summary.
  • Monitor the Company's utilization of the facility for acquiring qualifying loans.
  • Review the specific limitations on additional indebtedness and liens imposed by the new covenants.